Cargando…
The S1 protein of SARS-CoV-2 crosses the blood–brain barrier in mice
It is unclear whether SARS-CoV-2, which causes COVID-19, can enter the brain. SARS-CoV-2 binds to cells via the S1 subunit of its spike protein. We show that intravenously injected radioiodinated S1 (I-S1) readily crossed the blood-brain barrier (BBB) in male mice, was taken up by brain regions and...
Autores principales: | Rhea, Elizabeth M., Logsdon, Aric F., Hansen, Kim M., Williams, Lindsey M., Reed, May J., Baumann, Kristen K., Holden, Sarah J., Raber, Jacob, Banks, William A., Erickson, Michelle A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8793077/ https://www.ncbi.nlm.nih.gov/pubmed/33328624 http://dx.doi.org/10.1038/s41593-020-00771-8 |
Ejemplares similares
-
Blood-brain barrier penetration of non-replicating SARS-CoV-2 and S1 variants of concern induce neuroinflammation which is accentuated in a mouse model of Alzheimer’s disease
por: Erickson, Michelle A., et al.
Publicado: (2023) -
Intranasal Delivery: Effects on the Neuroimmune Axes and Treatment of Neuroinflammation
por: Rhea, Elizabeth M., et al.
Publicado: (2020) -
Interactions of SARS-CoV-2 with the Blood–Brain Barrier
por: Erickson, Michelle A., et al.
Publicado: (2021) -
The Effects of Viruses on Insulin Sensitivity and Blood–Brain Barrier Function
por: Raber, Jacob, et al.
Publicado: (2023) -
Prolonged culturing of iPSC-derived brain endothelial-like cells is associated with quiescence, downregulation of glycolysis, and resistance to disruption by an Alzheimer’s brain milieu
por: Williams, Lindsey M., et al.
Publicado: (2022)